Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASUS: Phenoconversion in Paediatric and AYA Lymphoma
NCT06383338Phase 1Recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of omeprazole and dextromethorphan, sponsored by Murdoch Children's Research Institute. Primary endpoint: Proportion of patients who consent to study and complete baseline and at least two longitudinal timepoints with successful measurement of probe drug MR at 24 months. Started Jul 2025; status: recruiting.
02
Drugs
omeprazoledextromethorphan
Beyond the preview
Go deeper on NCT06383338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06383338.